BRIEF published on 02/26/2025 at 07:05, 1 year 3 months ago Gerresheimer annonce une performance financière stable en 2024 malgré les défis Résultats Annuels Bormioli Pharma Croissance Des Revenus Perspectives Financières Défis Du Marché
PRESS RELEASE published on 02/26/2025 at 07:00, 1 year 3 months ago Gerresheimer delivers solid results in the financial year 2024 despite market headwinds Gerresheimer achieves solid results in FY 2024 despite market challenges with organic growth of 2.9% and adjusted EBITDA up 4.1%. Expansion and integration strategies set for growth in 2025 Growth Strategy Financial Results Market Challenges Organic Growth Gerresheimer
BRIEF published on 02/07/2025 at 16:31, 1 year 4 months ago Gerresheimer AG Engages in Preliminary Talks with Private Equity Firms Private Equity Takeover Offer Gerresheimer MDAX Investment Discussions
BRIEF published on 02/07/2025 at 16:31, 1 year 4 months ago Gerresheimer AG entame des discussions préliminaires avec des sociétés de capital-investissement Offre Publique D'achat Capital-investissement MDAX Gerresheim Discussions Sur Les Investissements
PRESS RELEASE published on 02/07/2025 at 16:26, 1 year 4 months ago EQS-Adhoc: Gerresheimer AG confirms discussions with private equity investors on potential takeover offer Gerresheimer AG confirms discussions with private equity investors on potential takeover offer Private Equity Takeover Offer Gerresheimer AG Discussions Potential
BRIEF published on 12/16/2024 at 09:05, 1 year 6 months ago Gerresheimer's Lasix ONYU Receives Tentative FDA Approval Innovation FDA Approval Healthcare Costs Gerresheimer Lasix ONYU
BRIEF published on 12/16/2024 at 09:05, 1 year 6 months ago Le Lasix ONYU de Gerresheimer reçoit une approbation provisoire de la FDA Innovation Approbation De La FDA Coûts Des Soins De Santé Gerresheim Lasix ONYU
PRESS RELEASE published on 12/16/2024 at 09:00, 1 year 6 months ago Gerresheimer: FDA grants Tentative Approval of SQ Innovation’s Lasix® ONYU* FDA grants Tentative Approval of SQ Innovation's Lasix ONYU by Gerresheimer for home treatment of fluid overload in congestive heart failure, with innovative on-body device technology FDA Gerresheimer Lasix ONYU Tentative Approval SQ Innovation
BRIEF published on 12/11/2024 at 08:05, 1 year 6 months ago Gerresheimer Completes Acquisition of Bormioli Pharma Group Pharmaceutical Packaging Market Expansion Financial Growth Gerresheimer Acquisition Bormioli Pharma Integration
BRIEF published on 12/11/2024 at 08:05, 1 year 6 months ago Gerresheimer finalise l'acquisition du groupe pharmaceutique Bormioli Croissance Financière Emballage Pharmaceutique Expansion Du Marché Acquisition De Gerresheimer Intégration De Bormioli Pharma
Published on 06/20/2026 at 01:00, 2 days 3 hours ago Onco-Innovations Announces Non-Brokered LIFE Offering
Published on 06/20/2026 at 00:00, 2 days 4 hours ago Onco-Innovations Reports Completion of 300g Active Pharmaceutical Ingredient for ONC010 Scale-Up Supporting IND-Enabling Development
Published on 06/19/2026 at 04:30, 3 days ago Uraniumx Discovery Corp. Announces Acquisition of Common Shares of Gold'n Futures Mineral Corp
Published on 06/19/2026 at 01:20, 3 days 3 hours ago American Hotel Income Properties REIT LP Reports Voting Results of Annual and Special Meeting
Published on 06/22/2026 at 04:05, 48 minutes ago Optro Accelerates Global Growth with Singapore Hub, Delivering Agentic GRC to APAC Enterprises
Published on 06/20/2026 at 21:25, 1 day 7 hours ago VIVATECH 2026 CELEBRATES ITS 10TH ANNIVERSARY WITH A RECORD EDITION SURPASSING 200,000 VISITORS
Published on 06/20/2026 at 06:00, 1 day 22 hours ago Successful debut of International Symposium on Emergency Response and Aeromedical Services in Hong Kong
Published on 06/19/2026 at 20:17, 2 days 8 hours ago 2CRSi SA: 2CRSi Responds Point-by-Point to the Grizzly Research Report and Reaffirms the Reality of Its Business Operations
Published on 06/19/2026 at 20:17, 2 days 8 hours ago 2CRSi SA: 2CRSi répond point par point au rapport de Grizzly Research et réaffirme la réalité de son activité
Published on 06/19/2026 at 19:33, 2 days 9 hours ago Déclaration hebdomadaire d'opérations effectuées du 15 au 19 juin 2026
Published on 06/19/2026 at 19:33, 2 days 9 hours ago Disclosure of transactions in own shares from June 15 to June 19, 2026
Published on 06/19/2026 at 19:23, 2 days 9 hours ago Imerys-06-2026-communique-capital-droits-de-vote-au-31-mai-2026
Published on 06/19/2026 at 19:23, 2 days 9 hours ago Imerys-06-2026-information-share-capital-and-voting-rights-as-of-31-May-2026
